Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds

Abstract

Chromium toxicity is strongly dependent on its oxidation state. Cr(VI) is carcinogenic and mutagenic, although its in vivo and in vitro toxic effects are related to its intracellular fate. Inside the cells, Cr(VI) is rapidly reduced to stable Cr(III). As Cr(V) and Cr(IV) species have been reported to be formed in the Cr(VI) reduction pathways, Cr(VI)induced damage is thought, at least in part, to arise from these hypervalent species. The study of Cr(VI) reduction mechanisms and the characterization of the effects of each reactive intermediate constitute important steps towards a better understanding of chromium toxicity. The purpose of this work is to enlarge the scope of Cr(VI)induced alterations in mouse to other chromium species. Our studies have led to the in situ preparation of a new Cr(V) complex, [Cr^V–BT]^2–, a stable compound at neutral pH, which mimics Cr(VI) reduction intermediates. The effect of Cr(V) on the histology of mice liver is assessed and compared with similar Cr(VI) assays. Liver toxicity was examined after single administrations of Cr(VI) or [Cr^V–BT]^2– to mice. Both compounds produced reversible hepatic damage in a time-dependent manner. However, Cr(V) toxic effects have proved to be more rapid than with Cr(VI), permitting the role of Cr(VI) intermediates formed during intracellular chromium reduction to be highlighted.

Keywords

chromium(V)chromium(VI)histology liver mice

References

IARC . Monographs on the evaluation of carcinogenic risks to humans: chromium, nickel and welding (Chapter 3) . Int Agency Res Cancer (Lyon) 1990; 49: 49–256 .

Codd R , Dillon CT , Levina A , Lay PA . Studies on the genotoxicity of chromium: from the test tube to the cell . Coord Chem Rev 2001; 216 17: 537–582 .

Sugden KD , Stearns DM . The role of Cr(V) in the mechanism of chromate-induced oxidative DNA damage and cancer . J Environ Pathol Toxicol Oncol 2000; 19: 215–230 .

Vasant C , Balamurugan K , Rajaram R , Ramasami T. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI)-induced toxicity . Biochem Biophys Res Commun 2001; 285: 1354–1360 .

Liu KJ , Jiang J , Swartz HM , Shi X. Low-frequency EPR detection of Cr(V) formation by Cr(VI) reduction in whole live mice . Arch Biochem Biophys 1994; 313: 248–252 .

Ueno S , Kashimoto T , Susa N , et al. Detection of dichromate(VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs . Toxicol Appl Pharmacol 2001; 170: 56–62 .

Arakawa H , Ahmad R , Naoui M , Tajmir Riahi HA . A comparative study of calf thymus DNA binding to Cr(III) and Cr(VI) ions . J Biol Chem 2000; 275: 10150–10153 .

Sudgen KD , Wetterhahn KE . EPR evidence for chromium(V) binding to phosphate and pyrophosphate: implications for Cr(V)–DNA interactions . Inorg Chem 1996; 35: 3727–3728 .

Krumpolc M , DeBoer BG , Rocek J. A stable chromium(V) complex. Synthesis, properties and crystal structure of potassium bis(2-hydroxy-2-methylbutyrato)-oxochromate(V) monohydrate . J Am Chem Soc 1978; 100: 45–153 .

10.

Codd R , Levina A , Zhang L , Hambley TW , Lay PA . Characterisation and X-ray absorption spectroscopy studies of bis(quinatoa(2-)oxochromate(V) . Inorg Chem 2000; 39: 990–997 .

11.

Levina A , Lay PA , Dixon NE . Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanato(2-)] oxochromate(V)in neutral aqueous solutions . Inorg Chem 2000; 39: 385–395 .

12.

Fonkeng BS , Moghaddas S , Bose RN . Electron paramagnetic resonance, kinetics of formation and decomposition studies of (bis(hydroxyethyl)aminotris(hydroxymethyl) methane)oxochromate(V): a model Cr(V) complex for DNA damage studies . J Inorg Biochem 1998; 72: 163–171 .

13.

Bose RN , Fonkeng BS . Mechanisms of DNA damage by chromium carcinogens . J Chem Soc (Chem Commun) 1996; 18: 2211–2212 .

14.

Zhang LB , Lay PA . EPR spectroscopic studies of the reactions of Cr(VI) with L-ascorbic acid inn buffer solutions: implications for understanding the role of chromium(V) and chromium(IV) species and the buffer dependences of in vitro DNA damage . Aust J Chem 2000; 53: 7–13 .

15.

Solis-Heredia MJ , Quintanilla-Vega B , Sierra-Santoyo A , et al. Chromium increases pancreatic metallothionein in the rat . Toxicology 2000; 142: 111–117 .

16.

Cheng L , Sonntag DM , De Boer J , Dixon K . Cr(VI)induced mutagenesis in the lungs of big blue transgenic mice . J Environ Pathol Toxicol Oncol 2000; 19: 239–249 .

17.

Liu KJ , Mäder K , Shi X , Swartz HM . Reduction of carcinogenic chromium(VI) on the skin of living rats . Magn Reson Med 1997; 38: 524–526 .

18.

Pires das Neves R , Santos TM , Pereira ML , Pedrosa de Jesus J. Chromium(VI) induced alterations in mouse spleen cells: a short term assay . Cytobios 2001; 106 (Suppl 1): 27–34 .

19.

Clodfelder BJ , Emamaullee J , Hepburn DD , Chakov NE , Nettles HS , Vincent JB . The trail of chromium(III) in vivo from the blood to the urine: the role of transferrin and chromodulin . J Biol Inorg Chem 2001; 6: 608–617 .

20.

Clarke MJ , Stubbs M. Interactions of metallopharmaceuticals with DNA. In Astrid and Helmut Sigel eds. Metal ions in biological systems (interactions of metal ions with nucleotides, nucleic acids, and their constituents), Chapter 21, Volume 32. New York: Marcel Dekker , 1996: 727–780.